In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...